Viewing Study NCT03959293


Ignite Creation Date: 2025-12-25 @ 1:26 AM
Ignite Modification Date: 2025-12-27 @ 11:01 PM
Study NCT ID: NCT03959293
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-07-08
First Post: 2019-05-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Clinical Trial Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatment of Patients With Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma
Sponsor: Federation Francophone de Cancerologie Digestive
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module